United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$417.57 USD
+7.70 (1.88%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $419.09 +1.52 (0.36%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, United Therapeutics Corporation has a market cap of $18.49B, which represents its share price of $409.87 multiplied by its outstanding shares number of 45.11M. As a large-cap company, UTHR's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
UTHR 417.57 +7.70(1.88%)
Will UTHR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for UTHR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for UTHR
Can MRK's New Drugs Drive Long-Term Growth Amid Looming Keytruda LOE?
Theravance Bio (TBPH) Up 9.8% Since Last Earnings Report: Can It Continue?
UTHR: What are Zacks experts saying now?
Zacks Private Portfolio Services
UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals
Why Is United Therapeutics (UTHR) Up 11.9% Since Last Earnings Report?
Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?
Other News for UTHR
UTHR makes New 52 Week Closing High on September 19
Director’s Major Stock Sale at United Therapeutics!
UTHR forms Golden Cross on September 18
Insider Sell: Judy Olian Sells Shares of United Therapeutics Corp (UTHR)
UTHR forms 180 Bullish Setup on September 17